InnoCare Pharma Inc.

Insider Reports History

Location
Princeton, NJ
Signature
/s/ Jisong Cui, Chairperson and CEO
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by InnoCare Pharma Inc.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Zenas BioPharma, Inc. 10%+ Owner Common Stock 5,000,000 $111,026,500 $22.21 07 Oct 2025 Direct

Insider Reports Filed by InnoCare Pharma Inc.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZBIO Zenas BioPharma, Inc. 07 Oct 2025 0 $0 3 10%+ Owner 15 Oct 2025, 06:12